Needle-Free Delivery: Technology and Market 2012-2022
NEW YORK, May 2, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Needle-Free Delivery: Technology and Market 2012-2022
http://www.reportlinker.com/p0788999/Needle-Free-Delivery-Technology-and-Market-2012-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic
Report Details
The technology and devices for needle-free delivery of drugs/vaccines has been available in the market since several decades. Although their market penetration has been low, the recent years have seen an increase in adoption, driven by the need for pain free delivery. Currently, the market for needle-free delivery devices is dominated by small medical device companies and academic researchers. These small scale companies are developing innovative needle-free delivery technologies, with the pharmaceutical companies entering into partnership with the device developers for using the technology for delivery of the company's drug. Teva Pharmaceuticals is using the Tjet injector system developed by Antares Pharma for delivery of TEV-TROPIN. We expect the pharmaceutical companies to begin developing drugs specifically for use with the needle-free systems, in the near future. According to our latest pharma report - Needle-Free Delivery: Technology and Market 2012-2022 - the global needle-free delivery devices market will be worth $2.1bn by 2016.
Needle-Free Delivery: Technology and Market 2012-2022 report forecasts the size and value of tleading national markets: the US, EU5, Japan, India and China. For each of these, visiongain identifies prevailing trends and strategies that will steer this emerging technology over the forecast period.
The needle-free delivery technology is advantageous for the drug and device developers as well as the end-users. The various factors backing the adoption of the needle-free devices include, but are not limited to, the ease of use, pain-free delivery, differentiation for product line extensions and life cycle management. However, the market is also faced with challenges of high cost, manufacturing inefficiencies, and reimbursement issues owing to the low cost of traditional delivery using hypodermic needles.
Needle-Free Delivery: Technology and Market 2012-2022 examines that sector critically, through a comprehensive review of information sources, both primary and secondary. In our report you find sales forecasts, growth rates and market shares. You also receive qualitative analyses, opinions from our survey and a review of companies and leading products. Discover over 70 tables and charts and two research interviews (shown in the accompanying lists).
Why you should buy Needle-Free Delivery: Technology and Market 2012-2022
In this report, you will receive the following benefits in particular:
• You will receive our assessment of the current market for needle-free delivery devices, with respect to the leading segments, products, companies and national markets
• You will discover sales trends for the overall needle-free delivery devices market from 2011 to 2022 - seeing where commercial growth will occur
• You will discover sales trends for the main segments - jet injectors and competing needle-free technology - from 2011 to 2022, with detailed discussions of market potential
• You will receive sales forecasts for leading national markets (US, Japan, EU5, India and China), with informed discussion
• You will assess leading manufacturers and products in the leading segments of the needle-free delivery devices market, with information on the pipeline products
• You will examine the strengths, weaknesses, opportunities and threats (SWOT analysis) facing the needle-free delivery devices market from 2012 onwards
• You will be able to investigate competition and opportunities influencing the needle-free delivery devices market from 2012 onwards
• You will see what will stimulate and restrain the market from 2012
• You will discover the unmet needs in the market, driving the growth from 2012 onwards
• You will view expert opinion from our survey, including two full interview transcripts.
You can order this report today
Anybody with an interest in the needle-free drug/vaccine delivery market should gain valuable information and insight from this new study by Visiongain, which analyses one of the most important sub-sectors of the medical device industry. The needle-free delivery devices market is undergoing many important shifts. You can stay ahead by ordering this report today.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Table of Contents
1. Executive Summary
1.1 Overview
1.2 Aims, Scope and Format of the Report
1.3 Research and Analysis Methods
1.4 Glossary of Terms Relating to Needle-Free Delivery
2. Introduction to Needle-Free Delivery of Drug/Vaccines
2.1 What is Needle-Free Technology?
2.1.1 History of Needle-Free Injections (NFI)
2.2 Why the Need for Needle-Free Delivery Technology?
2.2.1 Needle Stick Injury
2.2.1.1 Blood-Borne Pathogens and Needle Stick Injury
2.2.1.2 Accidental Needle Stick Injury: A Serious Healthcare Problem
2.3 Clinical Settings Where Needle-Free Delivery Technology Will Be Beneficial
2.3.1 Pain Management
2.3.2 Vaccine Delivery
2.3.2.1 The Global Vaccine Market, 2012-2022
2.3.2.2 Needle-Free Vaccine Delivery
2.3.2.3 Mass Immunisation
2.3.3 Insulin Delivery for Diabetics
2.3.4 Paediatric Injections
2.3.5 Other Uses For Needle-Free Injection Technology
2.4 Advantages and Disadvantages of Needle-Free Injections
2.5 The Needle-Free Delivery Market
2.6 Regulation of the Needle-Free Delivery Market
2.6.1 The US Regulation System
2.6.2 The European Regulation System
2.6.2.1 Post Marketing Surveillance in the EU
3. The Needle-Free Delivery Devices Market, 2010-2022
3.1 The Needle-Free Delivery Devices Market Overview
3.2 The Needle-Free Injection Market by Segment and Region, 2010
3.2.1 The Needle-Free Delivery Devices Market: Breakdown by Segment, 2010
3.2.2 The Needle-Free Delivery Market: Regional Breakdown, 2010
3.2.3 Regional Market Breakdown, 2010
3.2.3.1 The US Market
3.2.3.2 The EU Market
3.2.3.3 The Japanese Market
3.2.3.4 The Chinese Market
3.2.3.5 The Indian Market
3.3 The Needle Free Delivery Market Forecasts, 2011-2022
3.3.1 The Needle Free Delivery Market Forecasts, 2011-2016
3.3.2 The Needle Free Delivery Market Forecast, 2016-2022
3.4 The Needle-Free Delivery Market Forecasts by Region, 2011-2022
3.4.1 The US, EU and Japanese Markets, 2011-2022
3.4.1.1 The US Market
3.4.1.2 The EU Market
3.4.1.3 The Japanese Market
3.4.2 The Chinese and Indian Markets, 2011-2022
3.4.2.1 The Chinese Market
3.4.2.2 The Indian Market
4. The Jet Injectors: Technology and Market, 2010-2022
4.1 Introduction to Jet Injectors
4.2 Leading Products in the Jet Injectors Market
4.2.1 ZetaJet (Bioject Medical Technologies)
4.2.2 E-Jet 100 (Eurojet Medical)
4.2.3 PharmaJet (PharmaJet)
4.2.4 LectraJet (D'Antonio Consultants International)
4.2.5 Biojector 2000 (Bioject Medical Technologies)
4.2.6 Med-Jet (Medical International Technologies)
4.2.7 VISION/Tjet (Antares Pharma)
4.2.8 Glide System (Glide Pharma)
4.2.9 AdvantaJet (Activa)
4.2.10 J-Tip (National Medical Products)
4.2.11 SQ-Pen (Diabetes Management International)
4.2.12 SUMAVEL DosePro (Zogenix)
4.3 The Jet Injector Device Market, 2010-2022
4.3.1 The Jet Injector Device Market, 2010
4.3.2 The Jet Injectors Market Forecast, 2011-2022
4.3.2.1 Market Forecast for Leading Segments in The Jet Injectors Market, 2011-2016
4.3.2.2 Market Forecast for Leading Segments in The Jet Injectors Market, 2016-2022
4.4 Jet Injectors Development Pipeline
4.4.1 Zeneo (Crossject)
4.4.2 P.L.E.A.S.E. (Pantec Biosolutions)
4.4.3 Jupiter Jet (Bioject Medical Technologies)
4.4.4 Iject (Bioject Medical Technologies)
4.4.4.1 Iject R (Bioject Medical Technologies)
4.4.5 PyroFast (Pervormanc)
4.4.6 Relday (Zogenix)
4.5 Concluding Remarks
5. Competing Needle-Free Technologies, 2010-2022
5.1 Competing Needle-Free Technologies: Introduction
5.1.1 Novel Needle Technology
5.1.1.1 Microneedles
5.1.1.1.1 Solid Microneedles
5.1.1.1.2 Hollow Microneedles
5.1.1.1.3 Drug Microneedles
5.1.1.1.4 Selection of Microneedles
5.1.2 Inhalers
5.1.2.1 Inhalers for Vaccine Delivery
5.1.3 Patches (Transdermal Drug Delivery)
5.1.3.1 Patches for Vaccine Delivery
5.2 The Competing Needle-Free Technology Market, 2010
5.2.1 Competing Needle-Free Technology Market Definition
5.2.2 The Competing Needle-Free Technology Market, 2010
5.3 The Competing Needle-Free Technology Market Forecast, 2011-2022
5.3.1 The Competing Needle-Free Technology Market Forecast, 2010-2016
5.3.2 The Competing Needle-Free Technology Market Forecast, 2016-2022
5.3.3 Drivers and Restraints in the Competing Needle-Free Technology Market, 2012-2022
5.4 The Competing Needle-Free Technology Development Pipeline, 2012
5.4.1 Vaccine Delivery Using Micro-Shock Waves (Indian Institute of Science, Bangalore)
5.4.2 Microneedle Patch for the Polio Vaccine (Georgia Tech's School of Chemical and Biomolecular Engineering)
5.4.3 MicronJet (NanoPass Technologies)
5.4.4 AdminPen (nanoBioSciences)
5.4.5 PKA SoftTouch (PKA SoftTouch Corp)
5.4.6 Nanotechnology Syringes (Gwangju Institute of Science and Technology, South Korea)
5.4.7 Inhalable Measles Vaccine (Johns Hopkins Bloomberg School of Public Health and theUniversity of Colorado)
5.4.8 Nanotechnology Implant (University of California, San Francisco)
5.4.9 DrugMAT (TheraJect Inc)
5.4.10 MicroCor (Corium International)
5.5 Concluding Remarks
6. Drivers, Restraints and Trends in the Needle-Free Delivery Market
6.1 Drivers and Restraints in the Needle-Free Delivery Market, 2012-2022
6.1.1 Drivers
6.1.1.1 Market Moving Away From Traditional Needle/Syringe Injections
6.1.1.2 Patent Expiry Will Increase Competition
6.1.1.3 Safety Concerns Will Drive the Market
6.1.1.4 Booming Global Vaccines Market
6.1.2 Restraints
6.1.2.1 Expensive Technology With Currently Limited Market Penetration
6.1.2.2 Limited Clinical Data May Restrain The Market
6.1.2.3 Regulatory Bodies May Restrain The Market
6.2 SWOT Analysis of the Needle-Free Delivery Market
6.2.1 Strengths
6.2.1.1 Needle Free Injections Offer a Less Painful Alternative
6.2.1.2 No Specialist Training Required For Delivery
6.2.1.3 Reduction in Transport Costs
6.2.2 Weaknesses
6.2.2.1 Current Technology is Very Expensive
6.2.2.2 The Manufacturing Process is Inefficient
6.2.2.3 Many Drugs Need Reformulating Before Use with Needle-Free Injection Technology
6.2.3 Opportunities
6.2.3.1 Emerging Economies Offer Significant Growth Opportunities
6.2.3.2 Mass Immunisation Programs Across the Globe
6.2.3.3 DNA and Other Vaccine Offer Opportunity for Growth
6.2.4 Threats
6.2.4.1 Traditional Needles and Syringes are Very Cheap to Mass Produce
6.2.4.2 Limited Clinical Data Threatens to Stifle Innovation and Restrain the Market
7. Expert Opinions
7.1 Professor Gopalan Jagadeesh, American Institute of Aeronautics and Astronautics
7.1.1 The Current Needle-Free Device Market
7.1.2 Vaccine Delivery
7.1.3 Vaccine Delivery Using Micro-Shock Waves
7.2 Dr. Charles Potter, Glide Pharma
7.2.1 The Current Needle-Free Device Market
7.2.2 The Glide Solid Dose Injector (SDI) Technology
7.2.3 Manufacturing Aspects for Glide
7.2.4 Drug Delivery Using Glide
7.2.5 On the Microneedle Patch Technology
8. Conclusions
8.1 The Needle-Free Delivery Market, 2012-2022
8.2 Gas/Air Powered Jet Injectors Will Drive The Jet Injectors Market
8.3 Strong Pipeline Will Drive The Competing Needle-Free Injection Technology Market, 2012-2022
8.4 Concluding Remarks
Appendix A
Appendix B
Visiongain report evaluation form
List Of Tables
Table 2.1 Summary of the Global Vaccine Market ($bn), 2012-2022
Table 2.2 Rationale for Needle-free Vaccine Delivery
Table 2.3 Key Examples of Needle-free Vaccine Delivery Systems, 2012
Table 2.4 Key Examples of Needle-Free Insulin Delivery Systems for Diabetics
Table 2.5 Advantages and Disadvantages of Needle-Free Injections
Table 2.6 FDA Guidance on Regulation of Needle-Free Injectors, 2012
Table 3.1 The Total Needle-Free Delivery Market Sales ($m) by Segment, 2010
Table 3.2 The Needle-Free Delivery Market Sales ($m) by Region, 2010
Table 3.3 The European Needle-Free Delivery Market Sales ($m) by Country, 2010
Table 3.4 The Global Needle-Free Delivery Market Forecast ($m), 2010-2022
Table 3.5 The Needle-Free Delivery Market Forecast ($m) by Region, 2010-2016
Table 3.6 The Needle-Free Delivery Market Forecast ($m) by Region, 2016-2022
Table 3.7 Drivers and Restraints for the Chinese Needle-Free Delivery Market, 2012-2022
Table 4.1 Classification of Jet Injectors by Method of Propulsion
Table 4.2 The Strengths and Weaknesses of Jet Injectors, 2012
Table 4.3 Leading Products in the Jet Injectors Market, 2012
Table 4.4 The Jet Injectors Market Sales ($m) and Market Share (%) by Segment, 2010
Table 4.5 The Total Jet Injectors Market Forecast ($m), 2010-2022
Table 4.6 The Jet Injector Market Sales Forecast ($m), 2010-2016
Table 4.7 The Jet Injectors Market Forecast ($m), 2016-2022
Table 4.8 The Jet Injectors Development Pipeline, 2012
Table 5.1 Novel Needle Technology, by Needle Length, 2012
Table 5.2 The Microneedle Devices/Technologies for Vaccine/Drug Delivery, 2012
Table 5.3 Leading Inhalers in the Asthma Market, 2012
Table 5.4 Insulin Inhalers Previously Developed and Availability in 2012
Table 5.5 Vaccine Inhalers Currently Under Development, 2012
Table 5.6 The Competing Needle-Free Technology Market by Segment, 2010
Table 5.7 The Total Competing Needle-Free Technology Market Forecast ($m), 2010-2022
Table 5.8 The Competing Needle-Free Technology Market Forecast ($m) by Segments, 2010-2016
Table 5.9 The Competing Needle-Free Technology Market Forecasts ($m) by Segments, 2016-2022
Table 5.10 Drivers and Restraints Competing Needle-Free Technology Market, 2012-2022
Table 5.11 The Competing Needle-Free Technology Development Pipeline, 2012
Table 6.1 Drivers and Restraints For the Needle-Free Delivery Market, 2012-2022
Table 6.2 Leading Drugs That Have Lost Patent Protection, 2010-2012
Table 6.3 The Global Vaccine Market Forecast ($bn), 2010-2022
Table 6.4 SWOT Analysis of the Needle-Free Delivery Market, 2012-2022
Table 6.5 Average Price for Needle Free Drug/Vaccine Delivery Technology, 2012
Table 8.1 Leading Segments of the Needle-Free Delivery Devices Market ($m), 2010, 2011, 2016 and 2022
Table 8.2 Key Drivers and Restraints in the Needle-Free Injections Market, 2012-2022
List Of Figures
Figure 2.1 The Global Vaccine Market ($bn), 2012-2022
Figure 3.1 The Needle-Free Delivery Market Share (%) by Segment, 2010
Figure 3.2 The Needle-Free Delivery Market Sales ($m) by Segment, 2010
Figure 3.3 The Global Needle-Free Delivery Market Shares (%) by Region, 2010
Figure 3.4 The Global Needle-Free Delivery Market Sales ($m) by Region, 2010
Figure 3.5 The European Needle-Free Delivery Market Shares (%) by Country, 2010
Figure 3.6 The European Needle-Free Delivery Market Sales ($m) by Country, 2010
Figure 3.7 The Global Needle-Free Delivery Market Forecast ($m), 2010-2022
Figure 3.8 The Global Needle-Free Delivery Market Forecast ($m), 2010-2016
Figure 3.9 The US Needle-Free Delivery Market Forecast ($m), 2010-2016
Figure 3.10 The European Needle-Free Delivery Market Forecast ($m), 2010-2016
Figure 3.11 The Asian Needle-Free Delivery Market Forecast ($m), 2010-2016
Figure 3.12 The Global Needle-Free Delivery Market Forecast ($m), 2016-2022
Figure 3.13 The US Needle-Free Delivery Market Forecast ($m), 2016-2022
Figure 3.14 The EU Needle-Free Delivery Market Forecast ($m), 2016-2022
Figure 3.15 The Asian Needle-Free Delivery Market Forecast ($m), 2016-2022
Figure 4.1 The Jet Injectors Market Share (%) by Segment, 2010
Figure 4.2 The Jet Injectors Market Sales ($m) by Segment, 2010
Figure 4.3 The Total Jet Injectors Market Forecast ($m), 2010-2016
Figure 4.4 The Total Jet Injectors Market Forecast ($m), 2016-2022
Figure 4.5 The Jet Injectors Market Forecast ($m) by Segment, 2010-2016
Figure 4.6 The Total Jet Injectors Market Forecast ($m) by Segment, 2016-2022
Figure 5.1 The Competing Needle-Free Technology Market Share (%) by Segment, 2010
Figure 5.2 The Competing Needle-Free Technology Sales ($m) by Segment, 2010
Figure 5.3 The Total Competing Needle-Free Technology Market Forecast ($m), 2010-2022
Figure 5.4 The Total Competing Needle-Free Technology Market Forecast ($m), 2010-2016
Figure 5.5 The Total Competing Needle-Free Technology Market Forecast ($m) by Segment, 2010-2016
Figure 5.6 The Total Competing Needle-Free Technology Market Forecast ($m), 2016-2022
Figure 5.7 The Total Competing Needle-Free Technology Market Forecast ($m) by Segment, 2016-2022
Figure 6.1 The Global Vaccine Market Forecast ($bn), 2010-2022
Figure 6.2 The Transport Process for A Vaccine
Figure 8.1 Total Needle-Free Delivery Devices Market ($m), 2010, 2011, 2016 and 2022
Companies Listed
3M
Activa
AcuShot Inc
Akra Dermojet
AKTIV-DRY
Alkermes
Allen & Hanburys
Altea Therapeutics
American Institute of Aeronautics and Astronautics
Anesiva Inc
Antares Pharma
AstraZeneca
Australian Institute of Bioengineering and Nanotechnology
Becton Dickinson
Bioject Medical Technologies
Cambridge Consultants
Center for Devices and Radiological Health (CDRH).
Corium Group
Crossject Medical Technology
CSL Behring
D'Antonio Consultants International
Debiotech
Diabetes Management International
Echo Therapeutics
Eli Lilly & Co
Eloquest Healthcare
Emory University
Eurojet Medical
European Union Council
FDA MedWatch
Felton International
Ferndale Pharma Group, Inc
Ferring
Food & Drug Administration (FDA)
Generex
Georgia Tech School of Chemical and Biomolecular Engineering
GlaxoSmithKline
Glide Pharma
Gwangju Institute of Science and Technology, South Korea
Harvard University
Indian Institute of Science, Bangalore
Intercell
International Shock Wave Institute & Society for Shock Wave Research, India
JCR Pharmaceuticals
John Hopkins Bloomberg School of Public Health
Leiden University Medical Centre
LigoCyte
MannKind
Massachusetts Institute of Technology (MIT)
The Medical House Products Limited
Medical International Technologies
MedImmune
Merck Co
Mylan Laboratories
nanoBioSciences
Nanopass Technologies
National Medical Products Inc
Nektar Therapeutics
Novartis
Noven Pharmaceuticals
Novo Nordisk
Nycomed
Office of Combination Products (FDA)
Office of The Commissioner (FDA)
Owen Mumford Inc
Pantec Biosolutions
Pervormanc
Pfizer
Pharmacia & Upjohn Company
Pharmajet Inc
PKA SoftTouch Corp
PowderJect Pharmaceuticals
Procter & Gamble
Royal College of Nursing (RCN)
Sanofi Aventis
Sanofi-Pasteur
Schering Co
SFDA
Stat Medical Devices
Teva Pharmaceuticals
TheraJect Inc
Trinity-Chiese
UCB
University Erlangen-Nurnberg
University of California
University of Colorado
University of Queensland
University of Wisconsin Hospital
Valeritas
Walter Reed Army Institute of Research
World Health Assembly
World Health Organisation (WHO)
Zogenix
Zosano Pharma
To order this report:
In Vitro Diagnostic Industry: Needle-Free Delivery: Technology and Market 2012-2022
Check our Industry Analysis and Insights
__________________________
Contact Nicolas: [email protected]
US: (805)-652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article